16230, Hawthorn, Pennsylvania Prostate Cancer Score Provider Score

The Provider Score for the Prostate Cancer Score in 16230, Hawthorn, Pennsylvania is 63 when comparing 34,000 ZIP Codes in the United States.

An estimate of 94.87 percent of the residents in 16230 has some form of health insurance. 53.80 percent of the residents have some type of public health insurance like Medicare, Medicaid, Veterans Affairs (VA), or TRICARE. About 65.40 percent of the residents have private health insurance, either through their employer or direct purchase. Military veterans should know that percent of the residents in the ZIP Code of 16230 have VA health insurance. Also, percent of the residents receive TRICARE.

For the 128 residents under the age of 18, there is an estimate of 0 pediatricians in a 20-mile radius of 16230. An estimate of 0 geriatricians or physicians who focus on the elderly who can serve the 110 residents over the age of 65 years.

In a 20-mile radius, there are 638 health care providers accessible to residents in 16230, Hawthorn, Pennsylvania.

## Prostate Cancer Score Analysis: Hawthorn, PA (ZIP Code 16230)

Analyzing the healthcare landscape in Hawthorn, Pennsylvania (ZIP code 16230) necessitates a multi-faceted approach, particularly when considering prostate cancer care. This analysis focuses on evaluating the quality and accessibility of prostate cancer-related services, with specific attention to primary care availability, physician-to-patient ratios, and the integration of modern healthcare practices. The goal is to create a “Prostate Cancer Score” analysis, offering insights into the strengths and weaknesses of the local healthcare system for men at risk or diagnosed with prostate cancer.

The foundation of any effective prostate cancer care pathway is a robust primary care infrastructure. In Hawthorn, assessing primary care availability involves examining the number of practicing primary care physicians (PCPs) within and immediately surrounding the ZIP code. This includes not only family medicine doctors but also internal medicine specialists, as both are crucial for initial screenings, referrals, and ongoing management. The physician-to-patient ratio is a key metric. A higher ratio (fewer patients per doctor) generally indicates better access to care, allowing for more personalized attention and potentially earlier detection of health issues, including prostate cancer. Data from the US Census Bureau and the Pennsylvania Department of Health, combined with information from physician directories and insurance provider networks, would be used to calculate this ratio.

Beyond the raw numbers, the geographic distribution of PCPs is critical. Are the available doctors clustered in a single location, or are they spread out, providing better access for residents across the rural landscape of Hawthorn? This analysis considers the proximity of primary care practices to the population centers within the ZIP code. Factors like travel time, public transportation options (which may be limited in a rural area), and the presence of any physical barriers (like rivers or mountains) impacting access are assessed.

The quality of primary care also plays a vital role. This includes the availability of preventive screenings, such as prostate-specific antigen (PSA) tests, and the physician’s awareness of the latest prostate cancer guidelines. Information on the practices’ adherence to evidence-based guidelines, patient satisfaction scores (if available), and the presence of dedicated patient education programs are all factored into the assessment.

Specialist care, particularly urology, is essential for prostate cancer diagnosis and treatment. The availability of urologists within a reasonable travel distance is crucial. This analysis considers the number of urologists practicing within a defined radius of Hawthorn (e.g., 25 or 50 miles), along with their specialties and the types of procedures they offer (e.g., robotic surgery, brachytherapy). The presence of a multidisciplinary team, including oncologists, radiation oncologists, and other specialists, is also evaluated.

Standout practices within the region are identified based on a combination of factors. These include the use of advanced diagnostic and treatment technologies, patient outcomes data (if available and verifiable), and positive patient reviews. Practices demonstrating a commitment to patient-centered care, such as offering extended hours, multilingual services, or specialized programs for prostate cancer patients, are highlighted.

Telemedicine adoption is another critical element. The ability to access virtual consultations with PCPs, urologists, and other specialists can significantly improve access to care, especially for residents in rural areas. The analysis assesses the availability of telemedicine services within the local healthcare system, including the types of services offered, the ease of use of the platform, and the insurance coverage for telemedicine visits. The integration of remote patient monitoring technologies, such as wearable devices that track vital signs, is also considered.

Mental health resources are often overlooked, but they are vital for patients dealing with a prostate cancer diagnosis. The analysis evaluates the availability of mental health services, including psychiatrists, psychologists, and therapists, within the local area. This includes assessing the ease of access to these services, the insurance coverage for mental health treatment, and the availability of support groups or counseling programs specifically for prostate cancer patients and their families. The analysis considers the integration of mental health services into the overall care pathway, ensuring that patients have access to the support they need to cope with the emotional and psychological challenges of the disease.

The "Prostate Cancer Score" is a composite measure, incorporating all the factors described above. Each factor is assigned a weight based on its importance in the overall care pathway. For example, physician-to-patient ratio and the availability of specialists might be weighted more heavily than the availability of telemedicine services. The final score provides a comprehensive assessment of the healthcare landscape in Hawthorn, allowing for a comparative analysis of the quality and accessibility of prostate cancer care.

This analysis is not exhaustive. It is based on publicly available data and information gathered through research. The accuracy of the score depends on the availability and reliability of the data. The “Prostate Cancer Score” is intended to provide a general overview of the healthcare landscape and should not be considered a substitute for professional medical advice.

For a more in-depth understanding of the healthcare landscape in Hawthorn, including detailed maps of physician locations, access to care, and demographic data, consider exploring CartoChrome maps.